Skip to content
Screener

Roivant Sciences ROIV Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

Amgen logo
AmgenAMGN
$0—
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0-100%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25.84B+239%
Enterprise value$25.87B+239%
P/S3,431.3×+3,103×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0×0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001635088-26-000090
Line itemAmortized Cost(1)Gross Unrealized GainsGross Unrealized LossesFair Value
U.S. Treasury securities$1,892,411$25$(3,705)$1,888,731
Corporate bonds707,757—(2,862)704,895
Total marketable securities, available-for-sale$2,600,168$25$(6,567)$2,593,626

Item 1. Financial Statements (Unaudited).

FAQ

What is Roivant Sciences's unrealized gains on investments?
Roivant Sciences (ROIV) reported unrealized gains on investments of $25K in Q2 2026.
What does unrealized gains on investments mean?
The total unrealized gains on investments, typically related to available-for-sale securities.

Ask your AI about Roivant Sciences's unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude